SCHEMBL2994626

SCHEMBL2994626

CC=C1CN(C(=O)OCC)CCc2sccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
MDM2 Q00987 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 2/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 1/20 0.41
ALOX12 P18054 1/20 0.41
CASP1 P29466 1/20 0.41
HTT P42858 1/20 0.41
PDE4D Q08499 2/20 0.40
GAA P10253 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
NOS3 P29474 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2994625 1.00 ALDH1A1 (0.41) ALDH1A1NPSR1MAPTMEN1MAPK1
SCHEMBL12563513 1.00 ALDH1A1 (0.41) ALDH1A1NPSR1MAPTMEN1MAPK1
SCHEMBL1193758 0.88 ALDH1A1 (0.40) ALDH1A1NPSR1MAPTMEN1MAPK1
SCHEMBL1193760 0.88 ALDH1A1 (0.40) ALDH1A1NPSR1MAPTMEN1MAPK1
SCHEMBL1193762 0.88 ALDH1A1 (0.40) ALDH1A1NPSR1MAPTMEN1MAPK1
SCHEMBL12636631 0.88 ALDH1A1 (0.43) ALDH1A1NPSR1MAPTMEN1MAPK1
SCHEMBL985894 0.83 NOS3 (0.44) ALDH1A1NPSR1MAPTMEN1MAPK1
SCHEMBL1182615 0.82 SMN1; SMN2 (0.42) ALDH1A1NPSR1MAPTMEN1MAPK1
SCHEMBL12563516 0.80 MAPT (0.40) ALDH1A1NPSR1MAPTMEN1MAPK1
SCHEMBL1425864 0.78 KDM4E (0.46) ALDH1A1NPSR1MAPTMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778243-B1 SUBSTITUTED AZEPINE DERIVATIVES AS SEROTONIN RECEPTOR MODULATORS ATHERSYS INC (US) 2012-10-31 EP disclosed
US-20100190772-A1 Substituted Azepine Derivatives As Serotonin Receptor Modulators BENNANI YOUSSEF L 2010-07-29 US disclosed
US-7718647-B2 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. (US) 2010-05-18 US disclosed
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators HTR5A, HTR4, HTR7 ALDH1A1 1011/4885NPSR1 48/4885MAPT 4268/4885
US-20100190772-A1 Substituted Azepine Derivatives As Serotonin Receptor Modulators HTR5A, HTR4, HTR2C ALDH1A1 789/4885NPSR1 47/4885MAPT 4104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.